Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Oct;36(10):2342-5.
doi: 10.3899/jrheum.090370.

Outcome domains for studies of acute and chronic gout

Affiliations

Outcome domains for studies of acute and chronic gout

H Ralph Schumacher et al. J Rheumatol. 2009 Oct.

Abstract

Discussion and voting at OMERACT 9 confirmed 5 essential domains for outcomes of acute gout: pain, joint swelling, joint tenderness, patient global assessment and activity limitations. For studies in chronic gout 7 essential domains are: serum urate, acute gout attacks, tophus burden, health-related quality of life, activity limitations, pain, and patient global assessment. Implications of patient perspectives, discretionary domains for specific studies, measurement instruments and a possible responder index are under study.

PubMed Disclaimer

Similar articles

  • Progress in measurement instruments for acute and chronic gout studies.
    Grainger R, Taylor WJ, Dalbeth N, Perez-Ruiz F, Singh JA, Waltrip RW, Schlesinger N, Evans R, Edwards NL, Sivera F, Diaz-Torne C, MacDonald PA, McQueen FM, Schumacher HR. Grainger R, et al. J Rheumatol. 2009 Oct;36(10):2346-55. doi: 10.3899/jrheum.090371. J Rheumatol. 2009. PMID: 19820224
  • Outcome evaluations in gout.
    Schumacher HR, Taylor W, Joseph-Ridge N, Perez-Ruiz F, Chen LX, Schlesinger N, Khanna D, Furst DE, Becker MA, Dalbeth N, Edwards NL. Schumacher HR, et al. J Rheumatol. 2007 Jun;34(6):1381-5. J Rheumatol. 2007. PMID: 17552064
  • Quality of life and disability in patients with treatment-failure gout.
    Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, Edwards L, Kawata AK, Frank L, Waltrip R, Maroli A, Huang B; Gout Natural History Study Group; Sundy JS. Becker MA, et al. J Rheumatol. 2009 May;36(5):1041-8. doi: 10.3899/jrheum.071229. Epub 2009 Mar 30. J Rheumatol. 2009. PMID: 19332629
  • Establishing outcome domains for evaluating treatment of acute and chronic gout.
    Grainger R, Taylor WJ. Grainger R, et al. Curr Opin Rheumatol. 2008 Mar;20(2):173-8. doi: 10.1097/BOR.0b013e3282f36cf1. Curr Opin Rheumatol. 2008. PMID: 18349747 Review.
  • Outcome measures for acute and chronic gout.
    Schumacher HR Jr, Edwards LN, Perez-Ruiz F, Becker M, Chen LX, Furst DE, Joseph-Ridge N, Schlesinger N, Horowitz Z, Saag K, Boice JA, Yamanaka H; OMERACT 7 Special Interest Group. Schumacher HR Jr, et al. J Rheumatol. 2005 Dec;32(12):2452-5. J Rheumatol. 2005. PMID: 16331785 Review.

Cited by

LinkOut - more resources